These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 282625)

  • 21. Prevention of complement activation on the homologous cell membrane of nucleated cells as well as erythrocytes.
    Okada H; Tanaka H; Okada N
    Eur J Immunol; 1983 Apr; 13(4):340-4. PubMed ID: 6221932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibronectin-enhanced phagocytosis of an alternative pathway activator by human culture-derived macrophages is mediated by the C4b/C3b complement receptor (CR1).
    Bohnsack JF; O'Shea JJ; Takahashi T; Brown EJ
    J Immunol; 1985 Oct; 135(4):2680-6. PubMed ID: 3161946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Control of the amplification convertase of complement by the plasma protein beta1H.
    Weiler JM; Daha MR; Austen KF; Fearon DT
    Proc Natl Acad Sci U S A; 1976 Sep; 73(9):3268-72. PubMed ID: 1067618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.
    Farries TC; Lachmann PJ; Harrison RA
    Biochem J; 1988 May; 252(1):47-54. PubMed ID: 3421908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restriction of alternative complement pathway activation by sialosylglycolipids.
    Okada N; Yasuda T; Okada H
    Nature; 1982 Sep; 299(5880):261-3. PubMed ID: 7110347
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of gangliosides on activation of the alternative pathway of human complement.
    Michalek MT; Bremer EG; Mold C
    J Immunol; 1988 Mar; 140(5):1581-7. PubMed ID: 3346542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement activation by the surface of Plasmodium falciparum infected erythrocytes.
    Stanley HA; Mayes JT; Cooper NR; Reese RT
    Mol Immunol; 1984 Feb; 21(2):145-50. PubMed ID: 6369119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of membrane-associated sialic acid in the resistance of sheep erythrocytes to lysis by mouse complement.
    Rademaker PM; van Dijk H; Willers JM
    Immunol Lett; 1981 Oct; 3(4):221-5. PubMed ID: 7309131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of membrane phospholipids on activation of the alternative complement pathway.
    Mold C
    J Immunol; 1989 Sep; 143(5):1663-8. PubMed ID: 2527270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial sialic acid modulates activation of the alternative complement pathway of channel catfish (Ictalurus punctatus).
    Ourth DD; Bachinski LM
    Dev Comp Immunol; 1987; 11(3):551-64. PubMed ID: 3678558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the interaction between properdin and factor B, components of the alternative-pathway C3 convertase of complement.
    Farries TC; Lachmann PJ; Harrison RA
    Biochem J; 1988 Aug; 253(3):667-75. PubMed ID: 3140783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host modification of Sindbis virus sialic acid content influences alternative complement pathway activation and virus clearance.
    Hirsch RL; Griffin DE; Winkelstein JA
    J Immunol; 1981 Nov; 127(5):1740-3. PubMed ID: 6117595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limited tryptic cleavage of complement factor H abrogates recognition of sialic acid-containing surfaces by the alternative pathway of complement.
    Koistinen V
    Biochem J; 1992 Apr; 283 ( Pt 2)(Pt 2):317-9. PubMed ID: 1533511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Site-specific activation of the alternative pathway of complement. Synthesis of a hybrid molecule consisting of antibody and cobra venom factor.
    Parker CJ; White VF; Falk RJ
    Complement; 1986; 3(4):223-35. PubMed ID: 3643079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
    Kinoshita T; Takata Y; Kozono H; Takeda J; Hong KS; Inoue K
    J Immunol; 1988 Dec; 141(11):3895-901. PubMed ID: 3183384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The specificity of alternative complement pathway-mediated lysis of erythrocytes: a survey of complement and target cells from 25 species.
    Ish C; Ong GL; Desai N; Mattes MJ
    Scand J Immunol; 1993 Aug; 38(2):113-22. PubMed ID: 8346410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
    J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroids inhibit activation of the alternative-amplification pathway of complement.
    Packard BD; Weiler JM
    Infect Immun; 1983 Jun; 40(3):1011-4. PubMed ID: 6343236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro.
    Weiler JM; Gleich GJ
    J Immunol; 1988 Mar; 140(5):1605-10. PubMed ID: 3346544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.